Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Looking for participantsNCT05968690
What this trial is testing

Naltrexone and Propranolol Combined With Immunotherapy

Who this might be right for
Advanced Melanoma
Sarah Weiss 12
Testing effectiveness (Phase 2)Study completedNCT02073123
What this trial is testing

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

Who this might be right for
Metastatic MelanomaStage III MelanomaStage IV Melanoma
NewLink Genetics Corporation 131
Testing effectiveness (Phase 2)Study completedNCT02158520
What this trial is testing

Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaMucosal MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
Academic and Community Cancer Research United 24
Not applicableStudy completedNCT03504696
What this trial is testing

Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 400
Testing effectiveness (Phase 2)Ended earlyNCT00560118
What this trial is testing

Fotemustine in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Institut du Cancer de Montpellier - Val d'Aurelle 12
Testing effectiveness (Phase 2)Study completedNCT00299689
What this trial is testing

Phase II Trial of Ontak With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
James Graham Brown Cancer Center 69
Testing effectiveness (Phase 2)Study completedNCT00715793
What this trial is testing

Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hussein Tawbi 39
Not applicableNot Yet RecruitingNCT07794501
What this trial is testing

Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
European Institute of Oncology 200
Early research (Phase 1)Study completedNCT01738139
What this trial is testing

Ipilimumab and Imatinib Mesylate in Advanced Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmC-KIT Tyrosine Kinase Protein OverexpressionClinical Stage IV Cutaneous Melanoma AJCC v8+6 more
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT00094107
What this trial is testing

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
Pfizer 32
Not applicableLooking for participantsNCT07635732
What this trial is testing

Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy

Who this might be right for
Melanoma Stage IV
Medical University of Graz 50
Early research (Phase 1)Ended earlyNCT03674502
What this trial is testing

Safety of ADU-1604 in Adults With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Aduro Biotech, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT01009775
What this trial is testing

YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV Melanoma

Who this might be right for
Melanoma
Astellas Pharma Inc 64
Large-scale testing (Phase 3)Looking for participantsNCT06246916
What this trial is testing

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 560
Testing effectiveness (Phase 2)Study completedNCT00279058
What this trial is testing

The Role of Peptide-loaded Dendritic Cells to Augment the Therapeutic Effect of Interleukin-2

Who this might be right for
Metastatic Melanoma
Hadassah Medical Organization 24
Early research (Phase 1)Ended earlyNCT01826448
What this trial is testing

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

Who this might be right for
V600-mutated BRAF Unresectable MelanomaV600-mutated BRAF Metastatic MelanomaStage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF Inhibitor
Daiichi Sankyo 13
Testing effectiveness (Phase 2)WithdrawnNCT04703426
What this trial is testing

Sargramostim (GM-CSF) + PD-1

Who this might be right for
Unresectable MelanomaMetastatic MelanomaStage III Melanoma+1 more
Dana-Farber Cancer Institute
Early research (Phase 1)Looking for participantsNCT04855435
What this trial is testing

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorUveal Melanoma, MetastaticCutaneous Melanoma
MonTa Biosciences ApS 106
Testing effectiveness (Phase 2)Study completedNCT01328535
What this trial is testing

Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
Mayo Clinic 25
Next Page